BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30913092)

  • 1. Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.
    Shurell-Linehan E; DiPardo BJ; Elliott IA; Graham DS; Eckardt MA; Dry SM; Nelson SD; Singh AS; Kalbasi A; Federman N; Bernthal NM; Eilber FC
    Am J Clin Oncol; 2019 May; 42(5):426-431. PubMed ID: 30913092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
    Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
    Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
    LaFemina J; Qin LX; Moraco NH; Antonescu CR; Fields RC; Crago AM; Brennan MF; Singer S
    Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.
    Graham DS; Russell TA; Eckardt MA; Motamedi K; Seeger LL; Singh AS; Bernthal NM; Kalbasi A; Dry SM; Nelson SD; Elashoff D; Levine BD; Eilber FC
    Am J Clin Oncol; 2019 Oct; 42(10):739-743. PubMed ID: 31436746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
    Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
    Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.
    Carli M; Ferrari A; Mattke A; Zanetti I; Casanova M; Bisogno G; Cecchetto G; Alaggio R; De Sio L; Koscielniak E; Sotti G; Treuner J
    J Clin Oncol; 2005 Nov; 23(33):8422-30. PubMed ID: 16293873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?
    Gladdy RA; Qin LX; Moraco N; Edgar MA; Antonescu CR; Alektiar KM; Brennan MF; Singer S
    J Clin Oncol; 2010 Apr; 28(12):2064-9. PubMed ID: 20308666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interval Between Preoperative Radiation and Surgery Is Not Associated with Overall Survival for Soft-tissue Sarcomas: An Analysis of the National Cancer Database.
    Collier CD; Kim CY; Liu RW; Getty PJ
    Clin Orthop Relat Res; 2021 Mar; 479(3):506-517. PubMed ID: 32401002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.
    Greto D; Saieva C; Loi M; Desideri I; Delli Paoli C; Lo Russo M; Pezzulla D; Teriaca MA; Lucidi S; Visani L; Terziani F; Olmetto E; Becherini C; Bonomo P; Francolini G; Campanacci DA; Scoccianti G; Livi L
    Am J Clin Oncol; 2019 Oct; 42(10):749-754. PubMed ID: 31503061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
    Dunn GP; Spiliopoulos K; Plotkin SR; Hornicek FJ; Harmon DC; Delaney TF; Williams Z
    J Neurosurg; 2013 Jan; 118(1):142-8. PubMed ID: 23101443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
    Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
    J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant peripheral nerve sheath tumors of the trigeminal nerve: a systematic review of 36 cases.
    Schmidt RF; Yick F; Boghani Z; Eloy JA; Liu JK
    Neurosurg Focus; 2013 Mar; 34(3):E5. PubMed ID: 23451818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
    Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
    Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors.
    Lamm W; Schur S; Köstler WJ; Funovics P; Windhager R; Amann G; Panotopoulos J; Pokrajac B; Brodowicz T
    Oncology; 2014; 86(2):122-6. PubMed ID: 24480823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant peripheral nerve sheath tumor: analysis of treatment outcome.
    Wong WW; Hirose T; Scheithauer BW; Schild SE; Gunderson LL
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):351-60. PubMed ID: 9788415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience.
    Stucky CC; Johnson KN; Gray RJ; Pockaj BA; Ocal IT; Rose PS; Wasif N
    Ann Surg Oncol; 2012 Mar; 19(3):878-85. PubMed ID: 21861229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
    Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
    Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience.
    Sobczuk P; Teterycz P; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Kozak K; Falkowski S; Goryń T; Zdzienicki M; Morysiński T; Rutkowski P
    Surg Oncol; 2020 Dec; 35():276-284. PubMed ID: 32949967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.